<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04966754</url>
  </required_header>
  <id_info>
    <org_study_id>JS-2898</org_study_id>
    <nct_id>NCT04966754</nct_id>
  </id_info>
  <brief_title>Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring</brief_title>
  <official_title>Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangzhou Huyun Hospital Management Co., Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During the study, the resuscitation room, general wards and ICU were installed fixed or&#xD;
      mobile acquisition devices in the resuscitation room, the emergency department of Peking&#xD;
      Union Medical College Hospital, and the collection platform was set up. Patients with acute&#xD;
      diseases (infection, diabetes complications, etc.) caused by metabolic syndrome (obesity,&#xD;
      diabetes, etc.) were selected after informed consent. All medical intervention behaviors,&#xD;
      relevant medical records and medical outcome records within the collection scope of the&#xD;
      device platform were collected prospectively . And regular follow-up, guidance of patients&#xD;
      with metabolic syndrome control, while collecting all the lifestyle characteristics of&#xD;
      patients, some patients with metabolic cabin research, and observe the relevant medical&#xD;
      outcomes. After that, all the collected data were coded, and the influence of all lifestyle&#xD;
      and medical behavior interventions on patients' medical outcomes was studied by artificial&#xD;
      intelligence method.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of metabolic complications</measure>
    <time_frame>6 weeks</time_frame>
    <description>Relapse of acute metabolic disease, stability of biochemical metabolic indexes (such as glycosylated hemoglobin, BMI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication control</measure>
    <time_frame>3 weeks</time_frame>
    <description>The occurrence of metabolic complications, infection and cardiovascular events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of mortality</measure>
    <time_frame>6 months</time_frame>
    <description>30-day and 90-day mortality. Death due to cardiovascualr complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total cost of treatment</measure>
    <time_frame>3 weeks</time_frame>
    <description>Length of stay, length of stay in ICU, ventilator usage time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>6 months</time_frame>
    <description>Dynamic monitoring of quality of life through quality-of-life evaluation chart</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Metabolic Disturbance</condition>
  <condition>Metabolic Complication</condition>
  <condition>Infection</condition>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with metabolic syndrome (obesity, diabetes, etc.) cause acute disease attacks&#xD;
        (infection, diabetes complications, etc.).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diabetes and / or obesity (BMI&gt;=28).&#xD;
&#xD;
          -  Emergency room / emergency ward / EICU;&#xD;
&#xD;
          -  Be able to understand and agree the research protocol and sign the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women / lactation period;&#xD;
&#xD;
          -  The estimated survival time was less than 1 year;&#xD;
&#xD;
          -  Long term follow-up is not guaranteed;&#xD;
&#xD;
          -  Failure to comply with the protocol or procedure;&#xD;
&#xD;
          -  The collection of medical behavior data can not complete the de privacy or label after&#xD;
             de privacy;&#xD;
&#xD;
          -  Other researchers think that it is not suitable for inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Huadong Zhu, MD</last_name>
    <phone>13910696435</phone>
    <phone_ext>86</phone_ext>
    <email>huadongzhu@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wei Wang, Master</last_name>
    <phone>15600994998</phone>
    <email>wangwei00994998@126.com</email>
  </overall_contact_backup>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metabolic</keyword>
  <keyword>diabetes</keyword>
  <keyword>obesity</keyword>
  <keyword>infection</keyword>
  <keyword>complication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 6, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/54/NCT04966754/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

